藤黄果单独或与绿茶联用可致中重度肝损伤
基于DILIN网络2004至2018年1418例患者,鉴定22例藤黄果相关肝损伤(5例单用,16例联用绿茶,1例联用Ashwagandha)。肝损伤呈肝细胞型伴黄疸,91%住院,1例死亡、1例肝移植;HLA-B*35:01等位基因频率显著高于其他HDS及常规药物肝损伤。
要点
- 藤黄果相关肝损伤多为肝细胞型伴黄疸,91%需住院,可致死亡或肝移植。
- HLA-B*35:01等位基因在藤黄果HDS肝损伤中频率显著升高,提示免疫介导机制。
- 藤黄果单用或联用绿茶所致肝损伤临床无法区分。
核心结论
- 藤黄果单独或与绿茶联用所致肝损伤临床无法区分,呈肝细胞型伴黄疸,可致死亡或肝移植。
- HLA-B*35:01等位基因与藤黄果HDS肝损伤显著相关,提示免疫介导机制。
研究设计与样本
- 基于DILIN网络2004至2018年1418例患者,鉴定22例藤黄果相关肝损伤(单用5例,联用绿茶16例,联用Ashwagandha 1例)。
- 对照组为57例含绿茶但不含藤黄果的HDS肝损伤患者和103例其他HDS肝损伤患者。
主要发现
- 藤黄果组患者年龄17至54岁,肝损伤发生于开始服用后13至223天(中位51天)。
- 1例死亡,1例需肝移植,91%住院;肝损伤为肝细胞型伴黄疸。
- 藤黄果组转氨酶峰值显著更高(2001±1386 U/L,P<.018)。
- 藤黄果组总胆红素改善中位时间显著更短(10天 vs 17天和13天,P=.03)。
- HLA-B*35:01等位基因频率在含藤黄果HDS组为55%,显著高于其他HDS组19%(P=.002)和常规药物急性肝损伤组12%(P=2.55×10-6)。
临床怎么用
- 对服用藤黄果(尤其联用绿茶)的肝损伤患者,应考虑药物性肝损伤并详细追问HDS史。
- HLA-B*35:01等位基因检测可能有助于识别藤黄果相关肝损伤高风险个体。
局限性
- 样本量小(22例),来自单一时网络,可能存在选择偏倚。
- 未报告剂量-反应关系及机制验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Garcinia cambogia, either alone or with green tea, is commonly promoted for weight loss. Sporadic cases of liver failure from G cambogia have been reported, but its role in liver injury is controversial. METHODS: Among 1418 patients enrolled in the Drug-Induced Liver Injury Network (DILIN) from 2004 to 2018, we identified 22 cases (adjudicated with high confidence) of liver injury from G cambogia either alone (n = 5) or in combination with green tea (n = 16) or Ashwagandha (n = 1). Control groups consisted of 57 patients with liver injury from herbal and dietary supplements (HDS) containing green tea without G cambogia and 103 patients from other HDS. RESULTS: Patients who took G cambogia were between 17 and 54 years, with liver injury arising 13-223 days (median = 51) after the start. One patient died, one required liver transplantation, and 91% were hospitalized. The liver injury was hepatocellular with jaundice. Although the peak values of aminotransferases were significantly higher (2001 ± 1386 U/L) in G cambogia group (P < .018), the median time for improvement in total bilirubin was significantly lower compared with the control groups (10 vs 17 and 13 days; P = .03). The presence of HLA-B∗35:01 allele was significantly higher in the G cambogia containing HDS (55%) compared with patients because of other HDS (19%) (P = .002) and those with acute liver injury from conventional drugs (12%) (P = 2.55 × 10-6). CONCLUSIONS: The liver injury caused by G cambogia and green tea is clinically indistinguishable. The possible association with HLA-B∗35:01 allele suggests an immune-mediated mechanism of injury. CLINICAL TRIALS: gov number: NCT00345930.
引用
- Vuppalanchi R, Bonkovsky HL, Ahmad J, et al. Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. Clin Gastroenterol Hepatol. 2021. PMID: 34400337. doi:10.1016/j.cgh.2021.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。